ポスト

After >4 years, rituximab reduced the relapse rate from 0.366 to 0.136 in neuromyelitis optica spectrum disorder #NMOSD, with significant improvement in functional impairments and mostly mild infections. Link to the study ▶️ https://t.co/LX2eeOA1mx https://t.co/Oaf8IDG29H

メニューを開く

人気ポスト

もっと見る
Yahoo!リアルタイム検索アプリ